Kronik İnflamatuar Demiyelinizan Polinöropati
Özet
Kronik İnflamatuar Demiyelinizan Polinöropati (KIDP), periferik sinirleri ve sinir köklerini etkileyen, immün mekanizmalarla ortaya çıkan ilerleyici veya tekrarlayıcı bir nörolojik hastalıktır. Çocukluk çağında daha iyi bir prognoza sahip olan bu durum, temel olarak motor ve duyusal kayıplarla seyreden klinik bir tabloyla kendini gösterir. Tanı süreci, klinik bulguların yanı sıra detaylı elektrofizyolojik incelemeler ve tanı kriterlerine dayanmaktadır. İmmün modülatör tedaviler (IVIG, kortikosteroidler) hastalığın yönetiminde ve semptomların baskılanmasında kritik rol oynar.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an immune-mediated neurological disorder characterized by progressive or recurrent motor and sensory deficits affecting peripheral nerves and roots. While the condition can occur at any age, childhood cases typically show a better prognosis compared to adults. Diagnosis primarily relies on clinical assessment, specific diagnostic criteria, and electrodiagnostic studies to identify demyelination. Effective management involves immune-modulating therapies such as IVIG and corticosteroids to suppress the immune response and prevent long-term axonal damage.
Referanslar
Nevo Y, Topaloglu H. 88th ENMC International Workshop: Childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, 2000. Neuromuscul Disord. 2002;12:195–200.
Mahdi-Rogers M, Hughes RAC. Epidemiology of chronic inflammatory neuropathies in southeast England. Eur J Neurol. 2014;21:28–33.
Rabie M, Ashwal S, Nevo Y. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL, Pearl PL, Shevell MI, editors. Swaiman’s Pediatric Neurology. 6th edition. Elsevier; 2018. p.1086-9.
Iijima M, Koike H, Hattori N, Tamakoshi A, Katsuno M, Tanaka F, et al. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry. 2008;79:1040–3.
Sladky JT, Brown MJ, Berman PH. Chronic inflammatory demyelinating polyneuropathy of infancy: A corticosteroid responsive disorder. Ann Neurol. 1986;20:76-81.
De Sousa EA, Brannagan TH. 3rd: Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol. 2006;8:91-103.
Prineas JW. Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol. 1971;18:34.
Harbo T, Andersen H, Jakobsen J. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2008;38:1036.
Lewis RA, Muley SA, Shefner JM. Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis. In: Goddeau RP, editor. Uptodate. 2020 Oct 15. (24.04.2021).
Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurological Societies/Peripheral Nerve Society Guidelineon diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a Joint Task Force- Second revision. Eur J Neurol. 2021 Jul 30.
Ruts L, van Koningsveld R, van Doorn PA. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology. 2005; 65:138.
Figueroa JJ, Dyck PJ, Laughlin RS, Mercado JA, Massie R, Sandroni P, et al. Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2012;78:702.
Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of neurological Societies and Peripheral nerve Society. J.Peripher Nerv Syst. 2005 Sep;10(3):220-8.
Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst. 2010;15:1.
Ishikawa T, Asakura K, Mizutani Y, Ueda A, Murate KI, Hikichi C, et al. MR neurography for the evaluation of CIDP. Muscle Nerve. 2017;55:483.
Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017;1:CD010369.
Rossignol E, D'Anjou G, Lapointe N, Haddad E, Vanasse M. Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr Neurol. 2007;36:88-94.
Connolly AM. Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol. 2001;24:177-182.
